UK markets closed

Novo Nordisk A/S (NOVO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
849.00+6.00 (+0.71%)
At close: 04:59PM CET
Full screen
Previous close843.00
Open841.70
Bid849.00 x 0
Ask848.90 x 0
Day's range841.40 - 850.60
52-week range604.40 - 864.40
Volume1,038,200
Avg. volume1,539,910
Market cap1.898T
Beta (5Y monthly)0.32
PE ratio (TTM)36.63
EPS (TTM)23.18
Earnings date01 Feb 2023
Forward dividend & yield11.15 (1.31%)
Ex-dividend date12 Aug 2022
1y target est867.86
  • Motley Fool

    3 Healthcare Stocks That Could Set You Up For Life

    Until that day, companies in the healthcare sector that can stay ahead of the curve will continue to thrive. Although this market is competitive, the company made its name by targeting the life sciences industry. In other words, Veeva Systems is a specialist, not a generalist.

  • Zacks

    Prothena (PRTA) Earns Milestone Payment From Novo Nordisk

    Prothena (PRTA) earns a $40 million milestone payment from Novo Nordisk following the progress of NNC6019 in a phase II study for the treatment of ATTR cardiomyopathy.

  • Reuters

    Drug maker Novo Nordisk invests $744 million to expand Danish plant

    COPENHAGEN (Reuters) -Danish drug maker Novo Nordisk said on Tuesday it plans to invest 5.4 billion Danish crowns ($744 million) to expand its facilities in Bagsvaerd, Denmark. The world's biggest producer of diabetes drugs, Novo said the project is expected to be finalised in 2024 and create about 160 new jobs. The investment would add capacity in research and development for manufacturing of active pharmaceutical ingredients (API), the main biologically active components of medicines, to supply its global clinical trials.